SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

KORU Medical Systems, Inc. (KRMD)

NASDAQ: KRMD · Real-Time Price · USD
2.98-0.02 (-0.67%)
 
Market Cap136.88M-24.2%
Revenue (ttm)n/a+22.4%
Net Incomen/a+59.7%
EPSn/a+61.6%
Shares Out45.93M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume111,042
Open2.98
Previous Close3.00
Day's Range2.98 - 3.04
52-Week Range2.86 - 6.61
Betan/a
AnalystsBuy
Price Target6.00(+101.34%)
Earnings Daten/a
Insider Score
/ 100
KRMD Insider Score

KORU Medical Systems, Inc. has a live Insider Score.

Scored on 1 qualifying trade from 1 insider in the last 90 days.

Unlock the score

About KRMD

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

Address
100 Corporate Drive, Mahwah, NJ, 07430, United States
Market Cap
137 million
Employees
73
Industrial Classification
Medical Instruments & Supplies

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$210.59K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
-0.67%
5 Days
+1.71%
1 Month
-5.99%
6 Months
-28.88%
1 Year
-24.17%

$KRMD stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in KRMD holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by KRMD's directors and management

Net Shares Purchased by Insiders−40k−20k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

KRMD Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New KRMD patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to KRMD from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in KRMD

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$4.14M
IWMiShares Russell 2000 ETF$3.47M
VXFVanguard Extended Market ETF$1.72M
IWOiShares Russell 2000 Growth ETF$1.28M
VTWOVanguard Russell 2000 ETF$852.57K
IWCiShares Micro-Cap ETF$410.20K

Estimated from each fund’s disclosed top holdings × AUM

KRMD Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for KRMD is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from KRMD’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
8
Sells
0
Buy Value
$210.59K
Distinct Buyers
5

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.